Allogene Therapeutics Inc (NASDAQ:ALLO)

3.66
Delayed Data
As of Sep 22
 -0.06 / -1.61%
Today’s Change
3.63
Today|||52-Week Range
12.21
-41.81%
Year-to-Date
No recent news for Allogene Therapeutics Inc.

Today’s Trading

Previous close3.72
Today’s open3.76
Day’s range3.64 - 3.81
Volume56,180
Average volume (3 months)2,356,106
Market cap$611.8M
Data as of 3:59pm ET, 09/22/2023

Growth & Valuation

Earnings growth (last year)-22.80%
Earnings growth (this year)-1.66%
Earnings growth (next 5 years)+23.70%
Revenue growth (last year)-99.37%
P/E ratioNM
Price/Sales3,705.33
Price/Book0.79

Competitors

----
CDMOAvid Bioservices Inc+0.10+1.05%
EDITEditas Medicine Inc-0.15-1.88%
RAPTRapt Therapeutics In...-1.10-6.01%
Data as of 3:59pm ET, 09/22/2023

Financials

Next reporting dateNovember 8, 2023
EPS forecast (this quarter)-$0.56
Annual revenue (last year)$243.0K
Annual profit (last year)-$332.6M
Net profit margin-136,885.60%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
South San Francisco, California

Forecasts